IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,013,696 | -15.9% | 63,875 | 0.0% | 0.23% | -6.6% |
| Q2 2023 | $1,205,321 | +234.4% | 63,875 | -32.0% | 0.24% | +243.7% |
| Q1 2023 | $360,480 | -22.6% | 93,875 | 0.0% | 0.07% | -26.8% |
| Q4 2022 | $465,620 | +3.7% | 93,875 | -0.1% | 0.10% | -10.2% |
| Q3 2022 | $449,000 | +6.1% | 94,013 | 0.0% | 0.11% | +13.7% |
| Q2 2022 | $423,000 | -5.6% | 94,013 | -0.1% | 0.10% | +9.2% |
| Q1 2022 | $448,000 | -35.8% | 94,068 | 0.0% | 0.09% | -37.9% |
| Q4 2021 | $698,000 | +31.0% | 94,068 | 0.0% | 0.14% | +12.9% |
| Q3 2021 | $533,000 | -14.0% | 94,068 | 0.0% | 0.12% | -13.3% |
| Q2 2021 | $620,000 | -18.6% | 94,068 | 0.0% | 0.14% | -34.4% |
| Q1 2021 | $762,000 | +13.6% | 94,068 | -9.6% | 0.22% | +5.8% |
| Q4 2020 | $671,000 | +78.9% | 104,068 | 0.0% | 0.21% | +50.4% |
| Q3 2020 | $375,000 | -21.7% | 104,068 | 0.0% | 0.14% | -28.6% |
| Q2 2020 | $479,000 | +34.9% | 104,068 | 0.0% | 0.19% | +17.1% |
| Q1 2020 | $355,000 | -33.0% | 104,068 | +0.2% | 0.16% | -3.5% |
| Q4 2019 | $530,000 | +94.1% | 103,875 | -8.0% | 0.17% | +58.9% |
| Q3 2019 | $273,000 | +11.4% | 112,873 | 0.0% | 0.11% | +3.9% |
| Q2 2019 | $245,000 | -19.9% | 112,873 | 0.0% | 0.10% | -28.0% |
| Q1 2019 | $306,000 | -43.5% | 112,873 | 0.0% | 0.14% | -40.9% |
| Q4 2018 | $542,000 | -49.3% | 112,873 | 0.0% | 0.24% | -56.1% |
| Q3 2018 | $1,069,000 | -2.6% | 112,873 | 0.0% | 0.55% | -1.8% |
| Q2 2018 | $1,098,000 | -7.5% | 112,873 | 0.0% | 0.56% | -4.9% |
| Q1 2018 | $1,187,000 | +63.5% | 112,873 | -0.3% | 0.59% | +60.3% |
| Q4 2017 | $726,000 | -16.2% | 113,216 | 0.0% | 0.37% | -17.9% |
| Q3 2017 | $866,000 | +7.6% | 113,216 | 0.0% | 0.45% | +1.6% |
| Q2 2017 | $805,000 | +83.8% | 113,216 | 0.0% | 0.44% | +67.0% |
| Q1 2017 | $438,000 | +89.6% | 113,216 | 0.0% | 0.26% | +76.0% |
| Q4 2016 | $231,000 | -23.8% | 113,216 | 0.0% | 0.15% | -28.6% |
| Q3 2016 | $303,000 | -13.2% | 113,216 | 0.0% | 0.21% | -23.9% |
| Q2 2016 | $349,000 | -63.8% | 113,216 | 0.0% | 0.28% | -69.8% |
| Q1 2016 | $965,000 | -37.2% | 113,216 | 0.0% | 0.91% | -40.8% |
| Q4 2015 | $1,536,000 | +32.8% | 113,216 | -6.1% | 1.54% | +4.6% |
| Q3 2015 | $1,157,000 | -33.2% | 120,541 | 0.0% | 1.48% | -24.3% |
| Q2 2015 | $1,733,000 | +37.8% | 120,541 | -14.2% | 1.95% | +97.7% |
| Q1 2015 | $1,258,000 | +47.1% | 140,541 | +0.3% | 0.99% | -0.9% |
| Q4 2014 | $855,000 | -42.5% | 140,102 | -0.3% | 1.00% | -31.8% |
| Q3 2014 | $1,488,000 | -10.3% | 140,480 | +0.3% | 1.46% | -21.7% |
| Q2 2014 | $1,659,000 | -20.6% | 140,000 | 0.0% | 1.86% | -24.9% |
| Q1 2014 | $2,090,000 | +1.8% | 140,000 | 0.0% | 2.48% | +22.5% |
| Q4 2013 | $2,054,000 | -13.8% | 140,000 | 0.0% | 2.03% | -10.7% |
| Q3 2013 | $2,383,000 | -28.2% | 140,000 | -30.0% | 2.27% | -33.4% |
| Q2 2013 | $3,318,000 | – | 200,000 | – | 3.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |